DEA Revokes Registration for Seattle Nurse: A Critical Wake-Up Call
On June 20, 2025, the DEA revoked the registration of Scott Eric Hansen, an ARNP in Seattle, after an investigation revealed alarming activity, including writing at least 14 prescriptions for himself and up to 54 prescriptions for others, even after his state license had been suspended in 2024. Hansen was found prescribing high-risk controlled substances such as oxycodone/acetaminophen (Schedule II) …
Continue Reading
Critical Updates to 49 CFR Part 40: What Transportation Industry Stakeholders Must Know
The U.S. Department of Transportation (DOT) has implemented significant revisions to 49 CFR Part 40, which governs drug and alcohol testing procedures for transportation industry employees. These changes are designed to enhance safety, improve testing accuracy, and modernize processes. Here’s a comprehensive overview of the key updates: The DOT has broadened the drug testing panel to include four semi-synthetic opioids: …
Continue Reading
Navigating the 2024 Drug Testing Landscape: Key Considerations for Employers
With all the changes in the world of workplace safety and compliance, maintaining an effective drug testing program remains a cornerstone for employers committed to ensuring a safe and productive work environment. As we step into 2024, several key trends and regulatory updates necessitate a fresh look at how organizations approach drug testing. From the shifting sands of THC regulation …
Continue Reading
DOT Drug Testing
-
VettFirst
-
December 27, 2017
-
Drug Testing
-
0 Comments
DOT Drug Testing – Part 40 – Employee Notice The U.S. Department of Transportation (DOT) drug testing program will soon require testing for four semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone). The change is effective January 1, 2018. What does this mean for the employees? Beginning January 1, 2018, in addition to the existing DOT drug testing panel (that includes …
Continue Reading
